Brief: Champions Oncology to collaborate with Addario Lung Cancer Medical Institute

Champions Oncology

18/08/2017 13:30

Aug 18 (Reuters) - Champions Biotechnology  Inc  CSBR.O  
    * Champions Oncology announces research collaboration with 
the Addario Lung Cancer Medical Institute to develop unique 
cohort of patient-derived xenograft (PDX) models 
    * Champions Biotechnology  - deal with Addario Lung Cancer 
Medical Institute "ALCMI" to develop a cohort of PDX models in 
patients with ROS1 gene rearrangement 
 
Source text for Eikon:  ID:nPn5CS4l0a  
Further company coverage:  CSBR.O  
 
 ((Bangalore.newsroom@thomsonreuters.com;))